Annual Working Capital
-$6.74 M
-$6.82 M-8169.34%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual working capital is -$6.74 million, with the most recent change of -$6.82 million (-8169.34%) on December 31, 2022.
- During the last 3 years, NAVB annual working capital has fallen by -$5.83 million (-645.51%).
- NAVB annual working capital is now -114.62% below its all-time high of $46.10 million, reached on December 31, 1996.
Performance
NAVB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$3.48 M
-$2.17 M-167.07%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly working capital is -$3.48 million, with the most recent change of -$2.17 million (-167.07%) on September 30, 2023.
- Over the past year, NAVB quarterly working capital has dropped by -$2.17 million (-167.07%).
- NAVB quarterly working capital is now -107.54% below its all-time high of $46.10 million, reached on December 31, 1996.
Performance
NAVB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NAVB Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8169.3% | -167.1% |
3 y3 years | -645.5% | -167.1% |
5 y5 years | -216.9% | -167.1% |
NAVB Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8169.3% | at low | -4262.4% | +56.8% |
5 y | 5-year | -471.6% | at low | -157.8% | +56.8% |
alltime | all time | -114.6% | +88.6% | -107.5% | +94.1% |
Navidea Biopharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | -$3.48 M(+167.1%) |
Jun 2023 | - | -$1.30 M(-83.8%) |
Mar 2023 | - | -$8.05 M(+19.5%) |
Dec 2022 | -$6.74 M(-8169.3%) | -$6.74 M(+102.2%) |
Sep 2022 | - | -$3.33 M(-19.7%) |
Jun 2022 | - | -$4.15 M(+61.1%) |
Mar 2022 | - | -$2.58 M(-3186.1%) |
Dec 2021 | $83.50 K(-95.4%) | $83.50 K(-97.7%) |
Sep 2021 | - | $3.56 M(-40.8%) |
Jun 2021 | - | $6.02 M(+28.9%) |
Mar 2021 | - | $4.67 M(+157.5%) |
Dec 2020 | $1.81 M(-300.6%) | $1.81 M(+132.9%) |
Sep 2020 | - | $778.50 K(-59.5%) |
Jun 2020 | - | $1.92 M(-311.6%) |
Mar 2020 | - | -$907.80 K(+0.4%) |
Dec 2019 | -$903.80 K(-140.8%) | -$903.80 K(+164.3%) |
Sep 2019 | - | -$342.00 K(-112.9%) |
Jun 2019 | - | $2.65 M(-1527.7%) |
Mar 2019 | - | -$185.80 K(-108.4%) |
Dec 2018 | $2.22 M(-61.5%) | $2.22 M(+71.4%) |
Sep 2018 | - | $1.29 M(-34.4%) |
Jun 2018 | - | $1.97 M(-53.0%) |
Mar 2018 | - | $4.19 M(-27.3%) |
Dec 2017 | $5.76 M(-109.8%) | $5.76 M(-37.9%) |
Sep 2017 | - | $9.28 M(+4.1%) |
Jun 2017 | - | $8.92 M(-23.9%) |
Mar 2017 | - | $11.72 M(-119.9%) |
Dec 2016 | -$59.04 M(-1023.4%) | -$59.04 M(+8.7%) |
Sep 2016 | - | -$54.33 M(-2.2%) |
Jun 2016 | - | -$55.54 M(+18.0%) |
Mar 2016 | - | -$47.06 M(-836.0%) |
Dec 2015 | $6.39 M(-1486.2%) | $6.39 M(-26.7%) |
Sep 2015 | - | $8.73 M(-37.4%) |
Jun 2015 | - | $13.94 M(-385.8%) |
Mar 2015 | - | -$4.88 M(+957.8%) |
Dec 2014 | -$461.20 K(-101.8%) | -$461.20 K(-108.2%) |
Sep 2014 | - | $5.64 M(-60.8%) |
Jun 2014 | - | $14.41 M(-40.1%) |
Mar 2014 | - | $24.08 M(-7.5%) |
Dec 2013 | $26.04 M(+488.2%) | $26.04 M(-37.0%) |
Sep 2013 | - | $41.32 M(+72.1%) |
Jun 2013 | - | $24.01 M(+286.8%) |
Mar 2013 | - | $6.21 M(+40.2%) |
Dec 2012 | $4.43 M(-83.4%) | $4.43 M(-14.3%) |
Sep 2012 | - | $5.16 M(-60.6%) |
Jun 2012 | - | $13.09 M(-29.6%) |
Mar 2012 | - | $18.59 M(-30.4%) |
Dec 2011 | $26.70 M(+324.5%) | $26.70 M(-7.0%) |
Sep 2011 | - | $28.70 M(+349.0%) |
Jun 2011 | - | $6.39 M(-27.4%) |
Mar 2011 | - | $8.80 M(+40.0%) |
Dec 2010 | $6.29 M(+1.2%) | $6.29 M(+154.4%) |
Sep 2010 | - | $2.47 M(-42.3%) |
Jun 2010 | - | $4.28 M(-18.6%) |
Mar 2010 | - | $5.26 M(-15.4%) |
Dec 2009 | $6.21 M(+26.4%) | $6.21 M(-1.8%) |
Sep 2009 | - | $6.33 M(+68.1%) |
Jun 2009 | - | $3.77 M(-16.6%) |
Mar 2009 | - | $4.52 M(-8.2%) |
Dec 2008 | $4.92 M | $4.92 M(+76.1%) |
Sep 2008 | - | $2.79 M(-34.9%) |
Jun 2008 | - | $4.29 M(+97.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2008 | - | $2.17 M(-12.3%) |
Dec 2007 | $2.48 M(+28.6%) | $2.48 M(-220.0%) |
Sep 2007 | - | -$2.06 M(+129.2%) |
Jun 2007 | - | -$899.70 K(+81.6%) |
Mar 2007 | - | -$495.40 K(-125.7%) |
Dec 2006 | $1.92 M(-72.3%) | $1.92 M(-56.5%) |
Sep 2006 | - | $4.42 M(-23.7%) |
Jun 2006 | - | $5.80 M(-8.9%) |
Mar 2006 | - | $6.36 M(-8.5%) |
Dec 2005 | $6.95 M(-33.4%) | $6.95 M(-11.7%) |
Sep 2005 | - | $7.87 M(-10.9%) |
Jun 2005 | - | $8.83 M(-10.6%) |
Mar 2005 | - | $9.88 M(-5.3%) |
Dec 2004 | $10.43 M(+315.4%) | $10.43 M(+163.9%) |
Sep 2004 | - | $3.95 M(-3.1%) |
Jun 2004 | - | $4.08 M(-1.0%) |
Mar 2004 | - | $4.12 M(+64.0%) |
Dec 2003 | $2.51 M(+120.2%) | $2.51 M(+3065.6%) |
Sep 2003 | - | $79.30 K(-87.5%) |
Jun 2003 | - | $634.40 K(-5.3%) |
Mar 2003 | - | $669.90 K(-41.2%) |
Dec 2002 | $1.14 M(-72.0%) | $1.14 M(-17.8%) |
Sep 2002 | - | $1.39 M(-41.9%) |
Jun 2002 | - | $2.39 M(-26.6%) |
Mar 2002 | - | $3.25 M(-20.1%) |
Dec 2001 | $4.07 M(+6.9%) | $4.07 M(+0.1%) |
Sep 2001 | - | $4.07 M(+8.3%) |
Jun 2001 | - | $3.76 M(+0.9%) |
Mar 2001 | - | $3.72 M(-2.2%) |
Dec 2000 | $3.81 M(+281.9%) | $3.81 M(+25.8%) |
Sep 2000 | - | $3.03 M(+10.4%) |
Jun 2000 | - | $2.74 M(+16.3%) |
Mar 2000 | - | $2.36 M(+68.2%) |
Dec 1999 | $997.00 K(-1.0%) | - |
Jun 1999 | - | $1.40 M(-46.2%) |
Mar 1999 | - | $2.60 M(+158.3%) |
Dec 1998 | $1.01 M(-95.5%) | $1.01 M(-81.4%) |
Sep 1998 | - | $5.40 M(-44.3%) |
Jun 1998 | - | $9.70 M(-36.2%) |
Mar 1998 | - | $15.20 M(-32.0%) |
Dec 1997 | $22.35 M(-51.5%) | $22.35 M(-15.7%) |
Sep 1997 | - | $26.50 M(-20.2%) |
Jun 1997 | - | $33.20 M(-20.2%) |
Mar 1997 | - | $41.60 M(-9.8%) |
Dec 1996 | $46.10 M(+169.6%) | $46.10 M(+13.5%) |
Sep 1996 | - | $40.60 M(-4.0%) |
Jun 1996 | - | $42.30 M(+183.9%) |
Mar 1996 | - | $14.90 M(-12.9%) |
Dec 1995 | $17.10 M(0.0%) | $17.10 M(-6.0%) |
Sep 1995 | - | $18.20 M(+35.8%) |
Jun 1995 | - | $13.40 M(+123.3%) |
Mar 1995 | - | $6.00 M(-64.9%) |
Dec 1994 | $17.10 M(+92.1%) | $17.10 M(+228.8%) |
Sep 1994 | - | $5.20 M(+48.6%) |
Jun 1994 | - | $3.50 M(-39.7%) |
Mar 1994 | - | $5.80 M(-34.8%) |
Dec 1993 | $8.90 M(-25.8%) | $8.90 M(+45.9%) |
Sep 1993 | - | $6.10 M(-28.2%) |
Jun 1993 | - | $8.50 M(-19.8%) |
Mar 1993 | - | $10.60 M(-11.7%) |
Dec 1992 | $12.00 M | $12.00 M(+179.1%) |
Sep 1992 | - | $4.30 M |
FAQ
- What is Navidea Biopharmaceuticals annual working capital?
- What is the all time high annual working capital for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual working capital year-on-year change?
- What is Navidea Biopharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly working capital year-on-year change?
What is Navidea Biopharmaceuticals annual working capital?
The current annual working capital of NAVB is -$6.74 M
What is the all time high annual working capital for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual working capital is $46.10 M
What is Navidea Biopharmaceuticals annual working capital year-on-year change?
Over the past year, NAVB annual working capital has changed by -$6.82 M (-8169.34%)
What is Navidea Biopharmaceuticals quarterly working capital?
The current quarterly working capital of NAVB is -$3.48 M
What is the all time high quarterly working capital for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly working capital is $46.10 M
What is Navidea Biopharmaceuticals quarterly working capital year-on-year change?
Over the past year, NAVB quarterly working capital has changed by -$2.17 M (-167.07%)